MEDICAL TRANSCRIPTION BILLING, CORP
MEDICAL TRANSCRIPTION BILLING, CORP (MTBC) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 477 transactions totaling $11.8M, demonstrating a bearish sentiment with -$11.0M in net insider flow. The most recent transaction on Nov 8, 2022 involved a sale of 3,240 shares valued at $85.9K.
MTBC Insider Activity Summary
Who Is Buying MTBC Stock?
No significant insider buying has been recorded for MTBC in the recent period.
Who Is Selling MTBC Stock?
No significant insider selling has been recorded for MTBC in the recent period.
Is MEDICAL TRANSCRIPTION BILLING, CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MTBC is bearish with an Insider Alignment Score of 4/100 and a net flow of -$11.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
MTBC Frequently Asked Questions
Understanding MTBC Insider Activity
Insider trading at MEDICAL TRANSCRIPTION BILLING, CORP (MTBC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading MTBC stock, having executed 477 transactions in the past 90 days. The most active insider is Mahmud Ul Haq (Executive), who has made 65 transactions totaling $6.2M.
Related Tools
Track MEDICAL TRANSCRIPTION BILLING, CORP Insider Activity
Get notified when executives and directors at MTBC file new Form 4 transactions